Farmacogenética en el cáncer de mama: implicaciones de los genes del citocromo p450 en la supervivencia libre de la enfermedad en las mujeres jóvenes

Trujillo-Martínez, Miguel; Gómez-Flores-Ramos, Liliana; Sánchez-Zamorano, Luisa María; Reynoso-Noverón, Nancy; Grimaldo, Lizbeth; Albavera-Hernández, Cidronio; Flores-Luna, Lourdes.
Rev. senol. patol. mamar. (Ed. impr.) ; 35(4): 269-284, oct.-dic. 2022. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-211070

Documentos relacionados

  1. Deciphering breast cancer: from biology to the clinic.
  2. Bacteria in tumors "hit the road" together.
  3. Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
  4. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.
  5. Advancing community-academic partnerships to achieve breast health equity: Applying the community-based participatory model to build capacity for sustained impact.
  6. Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
  7. Genetic Ancestry-specific Molecular and Survival Differences in Admixed Patients With Breast Cancer.
  8. Development of a breast cancer prognostic model based on vesicle-mediated transport-related genes to predict immune landscape and clinical drug therapy.
  9. Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.
  10. Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer.